Anbio Biotechnology Cash And Cash Equivalents At Carrying Value

Quick Answer

Anbio Biotechnology reported Cash And Cash Equivalents At Carrying Value of $11.76 million for the year ending 2024.

  • Anbio Biotechnology showed an increase of +21.4% in Cash And Cash Equivalents At Carrying Value from 2023 to 2024.
  • This data is from Anbio Biotechnology's annual report (Form 10-K), filed with the SEC on April 28, 2025.
  • XBRL data for this metric is available from 2023 to 2024 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Historical annual values: Fiscal year 2024: $11.76 million | Fiscal year 2023: $9.69 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: